Location: Luxembourg
CIK: 0001053906 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 13, 2024
Total Value: $2.382B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CAVA | Cava Group Inc | 17,507,990 | $2.168B | 91.0% | $41.17 | +146.9% | COM | 148929102 |
| LXRX | Lexicon Pharmaceuticals Inc | 136,180,481 | $214M | 9.0% | $4.00 | -55.4% | COM NEW | 528872302 |